Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Reboxetine, a Selective Norepinephrine Reuptake Inhibitor, Is an Effective and Well-Tolerated Treatment for Panic Disorder PDF $40.00
$40.00
× Placeholder Increased Systemic Cortisol Metabolism in Patients With Schizophrenia and Bipolar Disorder: A Mechanism for Increased Stress Vulnerability? PDF $40.00
$40.00
× Placeholder Features Associated With the Delayed Initiation of Mood Stabilizers at Illness Onset in Bipolar Disorder PDF $40.00
$40.00
× Placeholder Seasonality of Birth in Seasonal Affective Disorder PDF $40.00
$40.00
× Placeholder Suicide in Primary Affective Disorders Revisited: A Systematic Review by Treatment Era PDF $40.00
$40.00
× Placeholder Reduction of Opioid-Withdrawal Symptoms With Quetiapine PDF $40.00
$40.00
× Placeholder Diagnosing Co-Occurring Substance-Related Disorders: Agreement Between SCID, Hispanic Clinicians, and Non-Hispanic Clinicians PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $280.00
Total $280.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe